In pharmaceutical automation, hardware is part of a validated system. Replacing a component is not just a procurement task. It can trigger a change-control process, require qualification activity, and generate compliance documentation before the new part is cleared for use.
Why sourcing is more complex than in other industries
- Change control: a like-for-like replacement with the same part number and revision carries a minimal burden, while a functional equivalent often needs an impact assessment, documentation updates, or qualification testing;
- Documentation and traceability: pharma facilities require full traceability of installed hardware, so sourcing outside standard channels means proving provenance, condition, and calibration status;
- Audit readiness: control-system hardware is subject to regulatory inspection, so every component in a validated system must stand up in an audit.
What to verify with quality/validation teams before ordering
- Full part number and revision, since revision can matter as much as the base part number;
- Whether the firmware version matches the validated configuration, as mismatches may need a software impact assessment;
- For GMP applications, whether calibration records are required before a unit can be installed and qualified;
- Whether hazardous-area (explosion-proof) or sanitary contact approvals are present on the specific part number;
- A change-control pre-assessment, confirming the sourced unit qualifies as like-for-like before purchase rather than after delivery.
None of this prevents pharma facilities from sourcing outside standard channels. It requires the sourcing process to account for validation implications up front, so that technical and compliance checks completed early avoid long delays later during installation and qualification.
Start Chat
Send an Email
